113 related articles for article (PubMed ID: 8083198)
1. A synthetic tris-sulfotyrosyl dodecapeptide analogue of the insulin receptor 1146-kinase domain inhibits tyrosine dephosphorylation of the insulin receptor in situ.
Liotta AS; Kole HK; Fales HM; Roth J; Bernier M
J Biol Chem; 1994 Sep; 269(37):22996-3001. PubMed ID: 8083198
[TBL] [Abstract][Full Text] [Related]
2. A peptide-based protein-tyrosine phosphatase inhibitor specifically enhances insulin receptor function in intact cells.
Kole HK; Garant MJ; Kole S; Bernier M
J Biol Chem; 1996 Jun; 271(24):14302-7. PubMed ID: 8662948
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of insulin receptor dephosphorylation by a synthetic dodecapeptide containing sulfotyrosyl residues as phosphotyrosyl mimetic.
Kole HK; Liotta AS; Garant MJ; Kole S; Bernier M
Indian J Biochem Biophys; 1997; 34(1-2):50-5. PubMed ID: 9343928
[TBL] [Abstract][Full Text] [Related]
4. Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases.
Kole HK; Smyth MS; Russ PL; Burke TR
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):1025-31. PubMed ID: 7487920
[TBL] [Abstract][Full Text] [Related]
5. Dynamic regulation of intact and C-terminal truncated insulin receptor phosphorylation in permeabilized cells.
Bernier M; Liotta AS; Kole HK; Shock DD; Roth J
Biochemistry; 1994 Apr; 33(14):4343-51. PubMed ID: 8155652
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the transmembrane protein tyrosine phosphatase lar by 3S-peptide-I enhances insulin receptor phosphorylation in intact cells.
Kole HK; Kole S; Mallory BP; Li PM; Goldstein BJ; Bernier M
J Basic Clin Physiol Pharmacol; 1998; 9(2-4):111-26. PubMed ID: 10212829
[TBL] [Abstract][Full Text] [Related]
7. A synthetic peptide derived from a COOH-terminal domain of the insulin receptor specifically enhances insulin receptor signaling.
Kole HK; Liotta AS; Kole S; Roth J; Montrose-Rafizadeh C; Bernier M
J Biol Chem; 1996 Dec; 271(49):31619-26. PubMed ID: 8940181
[TBL] [Abstract][Full Text] [Related]
8. Thiol-specific biotinylation of the insulin receptor in permeabilized cells enhances receptor function.
Bernier M; Nadiv O; Kole HK
Biochemistry; 1995 Jul; 34(26):8357-64. PubMed ID: 7599127
[TBL] [Abstract][Full Text] [Related]
9. Dephosphorylation of autophosphorylated insulin and epidermal-growth-factor receptors by two major subtypes of protein-tyrosine-phosphatase from human placenta.
Tappia PS; Sharma RP; Sale GJ
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):69-74. PubMed ID: 1715686
[TBL] [Abstract][Full Text] [Related]
10. Site-specific dephosphorylation and deactivation of the human insulin receptor tyrosine kinase by particulate and soluble phosphotyrosyl protein phosphatases.
King MJ; Sharma RP; Sale GJ
Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):413-8. PubMed ID: 1850986
[TBL] [Abstract][Full Text] [Related]
11. Sequential dephosphorylation of a multiply phosphorylated insulin receptor peptide by protein tyrosine phosphatases.
Ramachandran C; Aebersold R; Tonks NK; Pot DA
Biochemistry; 1992 May; 31(17):4232-8. PubMed ID: 1373652
[TBL] [Abstract][Full Text] [Related]
12. Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system.
Hashimoto N; Zhang WR; Goldstein BJ
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):569-76. PubMed ID: 1599438
[TBL] [Abstract][Full Text] [Related]
13. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling.
Kenner KA; Anyanwu E; Olefsky JM; Kusari J
J Biol Chem; 1996 Aug; 271(33):19810-6. PubMed ID: 8702689
[TBL] [Abstract][Full Text] [Related]
14. Dephosphorylation of insulin-receptor autophosphorylation sites by particulate and soluble phosphotyrosyl-protein phosphatases.
King MJ; Sale GJ
Biochem J; 1990 Feb; 266(1):251-9. PubMed ID: 1689998
[TBL] [Abstract][Full Text] [Related]
15. Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function.
Wilden PA; Kahn CR; Siddle K; White MF
J Biol Chem; 1992 Aug; 267(23):16660-8. PubMed ID: 1322912
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.
Burke TR; Kole HK; Roller PP
Biochem Biophys Res Commun; 1994 Oct; 204(1):129-34. PubMed ID: 7524496
[TBL] [Abstract][Full Text] [Related]
17. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR.
Zhang WR; Li PM; Oswald MA; Goldstein BJ
Mol Endocrinol; 1996 May; 10(5):575-84. PubMed ID: 8732688
[TBL] [Abstract][Full Text] [Related]
18. NMR analysis of regioselectivity in dephosphorylation of a triphosphotyrosyl dodecapeptide autophosphorylation site of the insulin receptor by a catalytic fragment of LAR phosphotyrosine phosphatase.
Lee JP; Cho H; Bannwarth W; Kitas EA; Walsh CT
Protein Sci; 1992 Oct; 1(10):1353-62. PubMed ID: 1303753
[TBL] [Abstract][Full Text] [Related]
19. Distinct functions of the two protein tyrosine phosphatase domains of LAR (leukocyte common antigen-related) on tyrosine dephosphorylation of insulin receptor.
Tsujikawa K; Kawakami N; Uchino Y; Ichijo T; Furukawa T; Saito H; Yamamoto H
Mol Endocrinol; 2001 Feb; 15(2):271-80. PubMed ID: 11158333
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the phosphotyrosyl phosphatase specificity of protein phosphatase type 2A and phosphotyrosyl phosphatase type 1B using phosphopeptides and the phosphoproteins p50/HS1, c-Fgr and Lyn.
Agostinis P; Donella-Deana A; Van Hoof C; Cesaro L; Brunati AM; Ruzzene M; Merlevede W; Pinna LA; Goris J
Eur J Biochem; 1996 Mar; 236(2):548-57. PubMed ID: 8612628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
